| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_acd222d02c242d011d1d1e68cc9885c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e64766f57342e7167b37e6ef2c7207d4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b3f3e8b186329d35d8118e71649e5012
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c54ccefe4c17232f4beb1897c4cde60d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7613b6875e4fe8e837c6e0ad904b8208 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-568
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-568
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-26 |
| filingDate |
2012-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5351c7de01217d11baadd54ca7a1f7e9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ebec4fb06bb9100ccf2c11fc3f2ce12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5cd8602b6b48c450a5ced5734a05b8ce
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_466db705ccb9abcd5d863248a98e9663 |
| publicationDate |
2012-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2012156821-A1 |
| titleOfInvention |
Intranasal lower dosage strength testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder |
| abstract |
The present invention relates to lower dosage strength pernasal testosterone gel formulations for intranasal administration and treatment methods for using the lower dosage strength pernasal testosterone gel formulations for treating a female subject with anorgasmia and/or hypoactive sexual desire disorder. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11090312-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10668084-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015069115-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019175290-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10111888-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11744838-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9757388-B2 |
| priorityDate |
2011-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |